SPACE PEPTIDES PHARMACEUTICAL

PEPTIDE DRUG DISCOVERY (CRO) AND MANUFACTURE (CDMO)

GDBspace enters into a licensing agreement with Humanwell Healthcare, for the discovery of Covid-19 inhibitors using GDBspace’s chemical space drug discovery engine

GDBspace AG, a company specialized in chemical space based drug discovery, announces today that it entered into a licensing agreement with Humanwell Healthcare, for the design of Covid-19 inhibitors for the treatment of coronavirus infections.

Dr. Lan Ma, Head of R&D at Ruibeixiyu Biotech, said:” In the race to combat coronavirus infections and the spread of the virus , we used GDBspace’s computational technology to identify molecules as inhibitors against Covid-19. This greatly cut the project time from months down to days.”

Dr. Sacha Javor, CTO at GDBspace, said: “We are glad to see that our technologies make a real-world impact, by increasing the speed and lowering the cost of the drug discovery, and hence to meet the acute need of patients in the latest coronavirus epidemic outbreak.”